Passage Bio Inc. (PASG)
0.48
-0.04 (-7.34%)
At close: Mar 03, 2025, 3:59 PM
0.48
-0.81%
After-hours: Mar 03, 2025, 04:00 PM EST
Passage Bio Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 21.71M | 34.6M | 128.97M | 135M | 158.87M | 24.86M |
| Short-Term Investments | 92.58M | 155.01M | 186.81M | 169.81M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 433K | 4.27M | 6.2M | 5.23M | 11.75M | 34K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 3.67M | 7.43M | 9.29M | 12.37M | 6.9M | 8.54M |
| Total Current Assets | 117.96M | 197.04M | 325.07M | 317.18M | 165.78M | 33.4M |
| Property-Plant & Equipment | 32.15M | 42.24M | 23.81M | 2.79M | 1.09M | 28K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 32.59M | 46.51M | 30.01M | 8.03M | 12.84M | 62K |
| Total Assets | 150.54M | 243.55M | 355.08M | 328.01M | 178.61M | 33.46M |
| Account Payables | 1.3M | 4.07M | 9.45M | 5.26M | 629K | 212K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 3.37M | 6.55M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 11.67M | 7.74M | 20.05M | 15.91M | 3.05M | 95K |
| Total Current Liabilities | 16.34M | 18.35M | 29.5M | 21.18M | 3.68M | 307K |
| Long-Term Debt | 22.92M | 23.83M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | 6.92M | 2.12M | 580K | 45.33M |
| Total Long-Term Liabilities | 22.92M | 23.83M | 6.92M | 2.12M | 580K | 45.33M |
| Total Liabilities | 39.26M | 42.18M | 36.42M | 23.29M | 4.26M | 45.63M |
| Total Debt | 26.29M | 27.11M | n/a | n/a | n/a | n/a |
| Common Stock | 5K | 5K | 5K | 4K | 3K | 2K |
| Retained Earnings | -594.47M | -492.41M | -356.28M | -170.9M | -58.66M | -13.03M |
| Comprehensive Income | -43K | -966K | -413K | -12K | -230.6K | -0.00 |
| Shareholders Equity | 111.28M | 201.37M | 318.66M | 304.71M | 174.35M | -12.17M |
| Total Investments | 92.58M | 155.01M | 186.81M | 169.81M | n/a | n/a |